The estimated Net Worth of Moshe Shoham is at least $1.81 Millón dollars as of 5 October 2017. Prof Shoham owns over 33,700 units of Microbot Medical Inc stock worth over $1,445,563 and over the last 7 years he sold MBOT stock worth over $368,050.
Prof has made over 2 trades of the Microbot Medical Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 33,700 units of MBOT stock worth $50,550 on 5 October 2017.
The largest trade he's ever made was selling 250,000 units of Microbot Medical Inc stock on 15 September 2017 worth over $317,500. On average, Prof trades about 141,850 units every 10 days since 2017. As of 5 October 2017 he still owns at least 1,558,390 units of Microbot Medical Inc stock.
You can see the complete history of Prof Shoham stock trades at the bottom of the page.
Prof. Moshe Shoham is the Co-Founder, Scientific Director & Member of Scientific Advisory Board at Microbot Medical Inc.
Prof Shoham is 69, he's been the Co-Founder y Scientific Director & Member of Scientific Advisory Board of Microbot Medical Inc since . There are no older and 13 younger executives at Microbot Medical Inc.
Moshe's mailing address filed with the SEC is C/O MICROBOT MEDICAL INC., 25 RECREATION PARK DRIVE, UNIT 108, HINGHAM, MA, 02043.
Over the last 8 years, insiders at Microbot Medical Inc have traded over $5,894,432 worth of Microbot Medical Inc stock and bought 10,000 units worth $11,000 . The most active insiders traders include Yoseph Bornstein, Investment Management Ltd A... y Moshe Shoham. On average, Microbot Medical Inc executives and independent directors trade stock every 37 days with the average trade being worth of $46,188. The most recent stock trade was executed by Yoseph Bornstein on 19 October 2020, trading 4,881 units of MBOT stock currently worth $38,755.
microbot medical was founded with the vision of pioneering micro invasive surgery, transforming one of the biggest trends in healthcare - minimally invasive surgery (estimated to be close to $20b by 2015); the company will provide transformational micro invasive technologies with the accuracy of robots and automated instruments to assist physicians in targeting the disease site with exquisite precision. microbot will solve one of the largest unmet needs in the medical field, where morbidity as a result of surgery is more frequently due to trauma involved in gaining access to the area to perform the intended procedure rather than from the procedure itself. through its unique platforms, microbot will reach multiple surgical spaces, capitalizing on the fact that minimally invasive techniques have been applied to most of the surgical specialties. microbot’s virob platform is an autonomous advancing micro robot (aamr), less then 1mm in diameter, which has the ability to advance (forward/bac
Microbot Medical Inc executives and other stock owners filed with the SEC include: